Scientists at the Changchun Institute of Applied Chemistry have developed a targeted cancer treatment platform combining low-intensity ultrasound with therapeutic agents. This strategy enhances selective tumor cell eradication while minimizing damage to healthy tissues, addressing chemotherapy’s traditional lack of specificity. The research highlights ultrasound’s role as a precise trigger in drug delivery systems, potentially improving safety and efficacy profiles for cancer patients.